These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25284117)

  • 1. Peripheral retinal ischemia after intravenous tissue plasminogen activator for central retinal artery occlusion.
    Joseph A; Rahimy E; Sarraf D
    Can J Ophthalmol; 2014 Oct; 49(5):e127-9. PubMed ID: 25284117
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergent fibrinolysis for central artery occlusion is inappropriate after 2 hours' ischemia.
    McLeod D
    Can J Ophthalmol; 2015 Jun; 50(3):249. PubMed ID: 26040227
    [No Abstract]   [Full Text] [Related]  

  • 3. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial.
    Schumacher M; Schmidt D; Jurklies B; Gall C; Wanke I; Schmoor C; Maier-Lenz H; Solymosi L; Brueckmann H; Neubauer AS; Wolf A; Feltgen N;
    Ophthalmology; 2010 Jul; 117(7):1367-75.e1. PubMed ID: 20609991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion.
    Kattah JC; Wang DZ; Reddy C
    Arch Ophthalmol; 2002 Sep; 120(9):1234-6. PubMed ID: 12215107
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis for artery occlusion.
    Arthur A; Aaron S
    Ophthalmology; 2011 Mar; 118(3):604; author reply 604-5. PubMed ID: 21376250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Major functional recuperation of branch retinal artery occlusion from thromboses in situ].
    Baeteman C; Loudot C; Combaz X; Arteaga C; Conrath J; Daubas P
    Can J Ophthalmol; 2008 Oct; 43(5):608-9. PubMed ID: 18982050
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous tissue plasminogen activator in central retinal artery occlusion.
    Falavarjani KG; Modarres M
    Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.
    Schrag M; Youn T; Schindler J; Kirshner H; Greer D
    JAMA Neurol; 2015 Oct; 72(10):1148-54. PubMed ID: 26258861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion.
    Daugeliene L; Niwa M; Hara A; Matsuno H; Yamamoto T; Kitazawa Y; Uematsu T
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2743-7. PubMed ID: 10937592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator after retinal artery occlusion.
    Marmor MF
    Ophthalmology; 1999 Dec; 106(12):2231-2. PubMed ID: 10599645
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
    Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
    Retina; 2009; 29(7):932-40. PubMed ID: 19584651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications.
    Hayreh SS
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):464-6; author reply 467-70. PubMed ID: 17119999
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
    Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis in acute retinal ischemia treated with tenecteplase.
    Kalaga SVP; Krishnan P; Krupa A L; Riyaz A; Vemula R
    Digit J Ophthalmol; 2024; 30(2):33-37. PubMed ID: 38962669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should Patients With Acute Central Retinal Artery Occlusion Be Treated With Intra-arterial t-PA?
    Egan RA; Van Stavern R
    J Neuroophthalmol; 2015 Jun; 35(2):205-9. PubMed ID: 25985436
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion.
    Chen CS; Lee AW; Campbell B; Paine M; Lee T; Fraser C; Grigg J; Markus R; Williams K; Coster DJ
    Int J Stroke; 2011 Feb; 6(1):87-9. PubMed ID: 21205247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator.
    Richard G; Lerche RC; Knospe V; Zeumer H
    Ophthalmology; 1999 Apr; 106(4):768-73. PubMed ID: 10201601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-arterial fibrinolysis in central artery occlusion].
    Schumacher M; Schmidt D; Wakhloo AK
    Radiologe; 1991 May; 31(5):240-3. PubMed ID: 1876695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Patients With Acute Central Retinal Artery Occlusion Be Treated With Intra-arterial t-PA?: Comment.
    Miller NR
    J Neuroophthalmol; 2015 Dec; 35(4):444. PubMed ID: 26457689
    [No Abstract]   [Full Text] [Related]  

  • 20. Should Patients With Acute Central Retinal Artery Occlusion Be Treated With Intra-arterial t-PA?: Response.
    Van Stavern RB; Egan RA
    J Neuroophthalmol; 2015 Dec; 35(4):444-5. PubMed ID: 26457688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.